Publication
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Journal Paper/Review - Dec 5, 2022
Johnston Stephen R D, Toi Masakazu, O'Shaughnessy Joyce, Rastogi Priya, Campone Mario, Neven Patrick, Huang Chiun-Sheng, Huober Jens, Jaliffe Georgina Garnica, Cicin Irfan, Tolaney Sara M, Goetz Matthew P, Rugo Hope S, Senkus Elzbieta, Testa Laura, Del Mastro Lucia, Shimizu Chikako, Wei Ran, Shahir Ashwin, Munoz Maria, San Antonio Belen, Andre Valerie, Harbeck Nadia, MartÃn Miguel
Johnston, Stephen R D
3
0
Toi, Masakazu
6
0
O'Shaughnessy, Joyce
7
0
Rastogi, Priya
7
0
Campone, Mario
5
0
Neven, Patrick
21
0
Huang, Chiun-Sheng
2
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
288
11
Jaliffe, Georgina Garnica
1
0
Cicin, Irfan
3
0
Tolaney, Sara M
2
0
Goetz, Matthew P
6
0
Rugo, Hope S
8
0
Senkus, Elzbieta
1
0
Testa, Laura
1
0
Del Mastro, Lucia
4
0
Shimizu, Chikako
2
0
Wei, Ran
3
0
Shahir, Ashwin
2
0
Munoz, Maria
1
0